Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 145

1.

Three-dimensional quantitative structure activity relationships (3-D-QSAR) of antihyperglycemic agents.

Kulkarni SS, Gediya LK, Kulkarni VM.

Bioorg Med Chem. 1999 Jul;7(7):1475-85.

PMID:
10465422
[PubMed - indexed for MEDLINE]
2.

3D-QSAR of histone deacetylase inhibitors: hydroxamate analogues.

Juvale DC, Kulkarni VV, Deokar HS, Wagh NK, Padhye SB, Kulkarni VM.

Org Biomol Chem. 2006 Aug 7;4(15):2858-68. Epub 2006 Jun 27.

PMID:
16855733
[PubMed - indexed for MEDLINE]
3.

Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.

Hou T, Zhu L, Chen L, Xu X.

J Chem Inf Comput Sci. 2003 Jan-Feb;43(1):273-87.

PMID:
12546563
[PubMed - indexed for MEDLINE]
4.

3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors.

Patel PD, Patel MR, Kaushik-Basu N, Talele TT.

J Chem Inf Model. 2008 Jan;48(1):42-55. Epub 2007 Dec 13.

PMID:
18076152
[PubMed - indexed for MEDLINE]
5.
6.

Development of predictive 3D-QSAR CoMFA and CoMSIA models for beta-aminohydroxamic acid-derived tumor necrosis factor-alpha converting enzyme inhibitors.

Murumkar PR, Gupta SD, Zambre VP, Giridhar R, Yadav MR.

Chem Biol Drug Des. 2009 Jan;73(1):97-107. doi: 10.1111/j.1747-0285.2008.00737.x.

PMID:
19152638
[PubMed - indexed for MEDLINE]
7.

Three-dimensional quantitative structure-activity relationship of 1,4-dihydropyridines as antitubercular agents.

Kharkar PS, Desai B, Gaveria H, Varu B, Loriya R, Naliapara Y, Shah A, Kulkarni VM.

J Med Chem. 2002 Oct 24;45(22):4858-67.

PMID:
12383011
[PubMed - indexed for MEDLINE]
8.

Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors.

Oprea TI, García AE.

J Comput Aided Mol Des. 1996 Jun;10(3):186-200.

PMID:
8808736
[PubMed - indexed for MEDLINE]
9.

3D-QSAR CoMFA, CoMSIA studies on substituted ureas as Raf-1 kinase inhibitors and its confirmation with structure-based studies.

Thaimattam R, Daga P, Rajjak SA, Banerjee R, Iqbal J.

Bioorg Med Chem. 2004 Dec 15;12(24):6415-25.

PMID:
15556759
[PubMed - indexed for MEDLINE]
10.
11.

Application of validated QSAR models of D1 dopaminergic antagonists for database mining.

Oloff S, Mailman RB, Tropsha A.

J Med Chem. 2005 Nov 17;48(23):7322-32.

PMID:
16279792
[PubMed - indexed for MEDLINE]
12.

3D-QSAR comparative molecular field analysis on opioid receptor antagonists: pooling data from different studies.

Peng Y, Keenan SM, Zhang Q, Kholodovych V, Welsh WJ.

J Med Chem. 2005 Mar 10;48(5):1620-9.

PMID:
15743203
[PubMed - indexed for MEDLINE]
13.

Structure-based rational quest for potential novel inhibitors of human HMG-CoA reductase by combining CoMFA 3D QSAR modeling and virtual screening.

Zhang QY, Wan J, Xu X, Yang GF, Ren YL, Liu JJ, Wang H, Guo Y.

J Comb Chem. 2007 Jan-Feb;9(1):131-8.

PMID:
17206841
[PubMed - indexed for MEDLINE]
14.

Ligands of neuronal nicotinic acetylcholine receptor (nAChR): inferences from the Hansch and 3-D quantitative structure-activity relationship (QSAR) Models.

Nicolotti O, Pellegrini-Calace M, Altomar C, Carotti A, Carrieri A, Sanz F.

Curr Med Chem. 2002 Jan;9(1):1-29. Review.

PMID:
11864064
[PubMed - indexed for MEDLINE]
15.

Comparative molecular field analysis of a series of paclitaxel analogues.

Zhu Q, Guo Z, Huang N, Wang M, Chu F.

J Med Chem. 1997 Dec 19;40(26):4319-28.

PMID:
9435901
[PubMed - indexed for MEDLINE]
16.
17.

3D QSAR comparative molecular field analysis on nonsteroidal farnesoid X receptor activators.

Honório KM, Garratt RC, Polikarpov I, Andricopulo AD.

J Mol Graph Model. 2007 Mar;25(6):921-7. Epub 2006 Sep 14.

PMID:
17055759
[PubMed - indexed for MEDLINE]
18.

Three-dimensional quantitative structure-activity relationships of mazindol analogues at the dopamine transporter.

Kulkarni SS, Newman AH, Houlihan WJ.

J Med Chem. 2002 Sep 12;45(19):4119-27.

PMID:
12213055
[PubMed - indexed for MEDLINE]
19.

Three-dimensional quantitative structure-activity relationship (3D-QSAR) studies of tricyclic oxazolidinones as antibacterial agents.

Gopalakrishnan B, Khandelwal A, Rajjak SA, Selvakumar N, Das J, Trehan S, Iqbal J, Kumar MS.

Bioorg Med Chem. 2003 Jun 12;11(12):2569-74.

PMID:
12757724
[PubMed - indexed for MEDLINE]
20.

3D-QSAR CoMFA/CoMSIA studies on 5-aryl-2,2-dialkyl-4-phenyl-3(2H)-furanone derivatives, as selective COX-2 inhibitors.

Puntambekar DS, Giridhar R, Yadav MR.

Acta Pharm. 2006 Jun;56(2):157-74.

PMID:
16613723
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk